Wyzer Biosciences

What Wyzer Biosciences does

Wyzer Biosciences is a privately held, Cambridge, MA-based DNA sequencing and DNA preparation service provider founded in 2011, operating from a single facility at 85 Bolton Street with 11–50 employees. Its core offering is full-service Sanger DNA sequencing on the ABI 3730xl platform (single pass, end reads, primer walking, and publication-quality double-stranded coverage), complemented by Next Generation Sequencing on the Illumina MiSeq and DNA preparation services spanning Mini to Giga scale, including endotoxin-free options and E. coli transformation. The company differentiates through proprietary wet-lab protocols for difficult templates (GC-rich regions, hairpins, homopolymers, and repeat stretches), an in-house built Laboratory Information Management System (LIMS), and bundled services such as free common primers, free QC sequencing for Midi-Giga preps, and reusable custom primer storage.

The business operates a direct-to-customer model accessed via a self-serve web portal (wyzerbio.com), with quote-based per-reaction pricing, 30-day invoice terms, and no public list pricing. Customers are split between academic and research institutions and biopharmaceutical industry partners, served both locally and globally via inbound sample logistics from a single Cambridge site. The company claims over 100 years of combined sequencing experience among staff, over 60 publications credited, and professional affiliations with DSRG/ABRF, the NY Academy of Sciences, and the Science Advisory Board. No external funding, acquisitions, patents, certifications, or social media presence are disclosed, indicating a founder-operated small service business rather than a venture-backed scale-stage entity.

Name

Wyzer Biosciences

Legal name

Wyzer Biosciences, Inc.

Website

https://wyzerbio.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Wyzer Biosciences is a privately held Cambridge, MA-based DNA sequencing and DNA preparation service provider offering Sanger (ABI 3730xl) and NGS (Illumina MiSeq) services to academic researchers and biopharmaceutical companies via direct, quote-based ordering.

Ownership category

akta.pro rank

Product category

Genomic / DNA Sequencing Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industry

Microbiome & Metagenomics Services (HLAGANAH)

Keywords

• DNA sequencing services
• DNA preparation services
• Next generation sequencing
• Sanger sequencing
• Primer design synthesis

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. DNA Sequencing Services: Full-service DNA sequencing including Sanger sequencing (single pass, end reads, primer walking, publication quality double-stranded coverage) and NGS-Illumina MiSeq services. Billed per reaction or quote-based for larger projects.
2. DNA Preparation Services: DNA preparation on all scales from Mini to Giga, including endotoxin-free options. Transformation services using chemically competent or electrocompetent E.coli cells. QC sequencing included free for Midi-Giga preps with reference sequence.
3. Primer Design and Synthesis: Design and synthesis of custom primers when requested. Primers can be stored and reused for future orders, saving time and cost for repeat customers.
4. Storage Services: Long term storage services for DNA samples and plates. May include pricing adjustments with 30-day written notice. Storage retention periods vary by sample type (30 days for standard, 6 months for DNA prep plates, 2 years for Midi-Giga preps).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Wyzer Biosciences is a full-service DNA sequencing and DNA preparation provider offering Sanger sequencing (single-pass reads, primer walking, publication-quality double-stranded coverage) on the ABI 3730xl platform, Next Generation Sequencing on Illumina MiSeq, and DNA preparation services from Mini to Giga scale. The company supports academic and biopharmaceutical researchers with an in-house LIMS, custom primer design, and proprietary protocols for difficult templates, accessed through a password-protected customer web portal.

Product overview

Wyzer Biosciences is a full-service DNA sequencing and DNA preparation provider offering an integrated portfolio of services centered around three core offerings: Precision Sanger Sequencing using ABI's 3730xl DNA analyzer, DNA Preparation services spanning Mini to Giga scales, and NGS via Illumina's MiSeq platform. The company operates an in-house LIMS system and provides end-to-end services from sample receipt through data delivery, including primer design, difficult template handling, and expert data analysis. Services are accessible through a customer web portal where users can submit orders, track progress, and retrieve results. Common sequencing primers are provided complimentary with Sanger services, and specialized protocols are available for difficult templates such as GC-rich regions and hairpins.

Differentiator

Problem solved

Functional benefit

Products and services

• Precision Sanger Sequencing

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature4 records

Partnerships

Three partnerships are on record, tiered minor.

• DSRG (Association for Biomolecular Resource Facilities)minorOthersProfessional membership affiliation. DSRG is an association for scientists doing DNA sequencing and operates as an arm of ABRF (Association for Biomolecular Resource Facilities).
• NY Academy of SciencesminorOthersProfessional membership affiliation. World's nexus of scientific innovation in the service of humanity.
• Science Advisory BoardminorOthersProfessional affiliation. Organization that conducts studies about products and services used by scientists.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• GENEWIZ (Azenta Life Sciences): GENEWIZ, now part of Azenta Life Sciences, is a leading DNA sequencing services provider offering Sanger, NGS, and synthetic biology services globally. It is the most directly comparable competitor to Wyzer, serving academic and biopharma customers with similar per-reaction and project-based offerings but at much larger scale.
• Macrogen: Macrogen is a global DNA sequencing services company based in South Korea with US operations, offering Sanger sequencing, NGS, and bioinformatics to research customers worldwide. It is a direct peer to Wyzer in sequencing-as-a-service targeting academic and biopharma clients.
• Psomagen: Psomagen (formerly Macrogen Clinical Labs) provides NGS, Sanger sequencing, and microbiome services to research and clinical customers, primarily in the US and Korea. It is comparable to Wyzer in offering researcher-facing sequencing services with both Sanger and NGS capabilities.
• ACGT Inc. ACGT Inc. is a US-based DNA sequencing and oligonucleotide synthesis service provider serving academic and industrial research customers. It is a direct peer to Wyzer in offering Sanger sequencing and related molecular biology services on a per-reaction basis.
• SeqGen Inc. SeqGen is a US-based DNA sequencing service provider specializing in Sanger and next-generation sequencing for research institutions. It directly competes with Wyzer in routine and custom sequencing services for the academic and biotech market.
• Elim Biopharmaceuticals: Elim Biopharmaceuticals provides DNA sequencing, oligonucleotide synthesis, and gene synthesis services primarily to researchers and biotech customers in the US. It is a direct peer to Wyzer in offering routine and custom molecular biology services with similar turnaround and pricing orientation.

Broad incumbents

• Eurofins Genomics: Eurofins Genomics is a large, global provider of genomic services including Sanger sequencing, NGS, oligonucleotides, and genotyping under the Eurofins scientific services umbrella. It competes with Wyzer in Sanger and NGS services for academic and industrial customers but operates at far greater scale and with broader portfolio offerings.

Emerging players

• Bioneer: Bioneer is a Korean molecular biology company offering DNA sequencing, oligonucleotide synthesis, and molecular diagnostics services. It is an emerging player comparable to Wyzer in providing integrated sequencing and DNA prep services to research customers.
• Fasteris SA: Fasteris is a Swiss genomics services provider offering Sanger sequencing, NGS, and bioinformatics to academic and industrial customers across Europe. It is an emerging niche player comparable to Wyzer in its focus on high-quality sequencing services with scientific expertise.

Regional players

• Source BioScience (now part of Eurofins): Source BioScience, now part of Eurofins, is a UK-based genomics services company offering Sanger and NGS for clinical and research customers, with regional strength in Europe. It is a regional peer to Wyzer in researcher-facing sequencing services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/wyzer-biosciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wyzer Biosciences